Evaluation of the antiangiogenic potential of AQ4N

Medicine and Dentistry

• Antiangiogenic 100%
• Neoplasm 66%
• Endothelial Cell 66%
• Skin Flap 66%
• Wound 66%
• In Vitro 33%
• Tumor Cell 33%
• Microvessel 33%
• Antiangiogenic Activity 33%
• Immunofluorescence 33%
• 3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide 33%
• Cell Contact 33%
• Dynein 33%
• Tirapazamine 33%
• Cytoskeleton 33%
• Tubulin 33%
• Cyclophosphamide 33%
• Chemotherapy Agent 33%
• Cytotoxic Chemotherapy 33%
• Low Drug Dose 33%
• Cytotoxicity 33%
• Antineoplastic Activity 33%
• Cell Migration 33%
• Matrigel 33%
• Phalloidin 33%
• Cell Invasion 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiangiogenic 100%
• Neoplasm 75%
• Mitoxantrone 50%
• Fumagillin 50%
• Wound 50%
• Phalloidin 25%
• Tubulin 25%
• Antitumor Activity 25%
• Dynein Adenosine Triphosphatase 25%
• Cytotoxic Chemotherapy 25%
• Chemotherapy Agent 25%
• 3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide 25%
• Matrigel 25%
• Cytotoxicity 25%
• Cyclophosphamide 25%
• Tirapazamine 25%